Influenza Vaccinations: A Leadership Approach by Meister, Christine Ann
Florida Public Health Review
Volume 9 Article 6
February 2012
Influenza Vaccinations: A Leadership Approach
Christine Ann Meister
Follow this and additional works at: https://digitalcommons.unf.edu/fphr
Part of the Public Health Commons, and the Social and Behavioral Sciences Commons
This Article is brought to you for free and open access by the Brooks
College of Health at UNF Digital Commons. It has been accepted for
inclusion in Florida Public Health Review by an authorized administrator
of UNF Digital Commons. For more information, please contact Digital
Projects.
© February 2012 All Rights Reserved
Recommended Citation
Meister, Christine Ann (2012) "Influenza Vaccinations: A Leadership Approach," Florida Public Health Review: Vol. 9 , Article 6.
Available at: https://digitalcommons.unf.edu/fphr/vol9/iss1/6




Influenza Vaccinations: A Leadership 
Approach 
 
Christine Ann Meister, BS 
 
ABSTRACT 
Each year thousands of individuals in the United States are diagnosed with cases of seasonal influenza (flu) and the recent 
pandemic strain of H1N1 influenza. Complications of the flu can lead to serious health issues resulting in hospitalization and 
even death. Vaccination for seasonal flu and H1N1 can decrease the number of cases of the flu, thus decreasing the number of 
complications resulting from infection. Unfortunately, a large percentage of the population chooses not to get vaccinated every 
year for the seasonal flu because they do not trust vaccine safety and effectiveness. To gain the public’s trust and increase the 
number of influenza inoculations, the Centers for Disease Control and Prevention (CDC) and state health departments should 
incorporate John Kotter’s eight-stage plan for leadership change. Kotter’s plan helps groups create goals that eventually lead to 
a cultural change. Goals of educating both the general population and individuals at risk of complications from the flu will 
lead to an increase in trust and eventual reduction of influenza complications and deaths.  
Florida Public Health Review, 2012; 9, 42-45. 
 
Background 
Every year tens of thousands of people get sick 
from the flu. The Centers for Disease Control and 
Prevention (CDC) estimate that from 1976 to 2006, 
between 3,000 and 49,000 deaths were caused by flu 
related illnesses (CDC, 2011a). The incidence of flu 
and incidence of complications from the virus can be 
reduced and even prevented by increasing the 
number of people who are vaccinated each year 
against seasonal and H1N1 influenza. Unfortunately, 
a large portion of the population does not get 
vaccinated. This paper addresses the main reasons 
why at-risk populations choose not to get vaccinated 
for the flu and provides an action plan for increasing 
the number of people who are vaccinated each year.   
 
Significance of Problem 
The CDC (2011b) estimates that between April 
2009 and April 2010, during the pandemic H1N1 flu 
season, between 43 million and 89 million cases of 
H1N1 were reported in the United States, resulting 
in 8,870-18,300 deaths. Between October 3, 2010 
and May 21, 2011, the World Health Organization 
(WHO) and National Respiratory and Enteric Virus 
Surveillance System (NREVSS) recorded 40,282 
cases of influenza A (including both H3N2 and 
H1N1 viruses) and 13,944 cases of influenza B 
viruses. These numbers may be underestimated, 
however, because not all cases during the flu season 
were reported and tested. Although that season was 
less severe than the 2009-2010 season, it was more 
severe than the 2008-2009 flu season (CDC, 2011b).   
Everyone aged six months and older should get 
vaccinated, especially those who are at risk for 
severe complications for the flu and those who work 
or live in close proximity to those at risk (CDC, 
2011c). Vaccine campaigns are run by both the CDC 
and state health departments; however vaccination 
turnouts for the seasonal flu are not high. In the 
June 10, 2011 Morbidity and Mortality Weekly Report 
(MMWR), the CDC estimated that nationwide about 
49% of children between six months and 17 years of 
age were vaccinated during the 2010-2011 flu 
season, about 6.7% higher than the previous flu 
season. About 30.2% of adults between 18 and 49 
years of age, 45.6% of adults between 50 and 64 
years of age, and 68.6% of adults aged 65 and older 
were vaccinated during the 2010-2011 season. 
According to the CDC (2011c) 48.4% of at-risk 
adults with a medical condition that increases their 
chance for complications caused by influenza were 
inoculated for the seasonal flu last year. 
If we are to increase the number of flu vaccine 
inoculations each season, an action plan needs to be 
put in place. A movement structured around a 
strong leadership process may help gain the public’s 
trust in the CDC, state health departments and the 
safety of vaccination techniques. 
 
Factors Related to or Affecting the Problem 
Many of the reasons why the general population 
does not get vaccinated revolve around the idea that 
people cannot trust the CDC or that vaccinations are 
a money-making ploy for the drug companies that 
create them (Swine Flu Information, 2011). Ramsey 
and Marczinski (2011) found that college students 
who chose not to get vaccinated for H1N1, did so 
because they believed that the vaccine would not 
work, that the vaccine had not been tested enough, 
and because they were worried about both serious 
and minor side effects. Pregnant women are also 
identified as an at-risk group for complications due 
to H1N1 influenza. The most common reasons for 
pregnant women to choose not to get vaccinated for 
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the H1N1 and seasonal influenza was because they 
had not been vaccinated in the past, because they 
were afraid for the health of their babies and because 
they were concerned about their own health 
(Ahluwalia, Singleton, Jamieson, Rasmussen and 
Harrison, 2011).   
The choice not to get vaccinated is an important 
decision in personal autonomy. However, the 
public’s mistrust of the safety of vaccines is 
unfounded. Vaccines are rigorously tested by drug 
companies before the FDA can approve of them. The 
CDC and U.S. Vaccine Adverse Event Reporting 
System (VEARS) reported that during the 2010-11 
flu season, an estimated 163 million doses of 
influenza vaccine were administered in the U.S.  As 
of December 14, 2010, VAERS received 6845 
reports of adverse affects to the vaccine. Of those 
reports, 415 were considered serious side effects. 
Included among those 415 reports were 18 reports 
of deaths and 51 reports of Guillian Barré Syndrome 
(GBS). It had not been confirmed, however, that 
those 18 deaths and GBS reports were a direct result 
of the influenza vaccine (VEARS, 2011). 
It is important that vaccine safety concerns are 
not misrepresented in the media. The CDC, state 
health departments and the media need to trust that 
the public will recognize safety concerns and still 
and will be able to make the appropriate decision 
regarding their heath and the safety of others. The 
risks should be discussed in a clear and informative 
manner to protect personal autonomy. At the same 
time, the public needs to be educated about the 
overall benefits vaccinations can have for both 
individuals and the nation as a whole.  
   
Implications for Leadership 
John Kotter outlines an eight-stage process of 
leadership in his book Leading Change. His outline 
begins with establishing a need for change and ends 
with ensuring that the change is ingrained into the 
culture of the population. Incorporating Kotter’s 
leadership action plan into vaccine campaigns may 
help to increase the number of influenza vaccine 
inoculations and thus decrease the number of flu-
related illnesses and deaths each year. 
Step 1: Establish a Sense of Urgency 
The first step in Kotter’s leadership action plan 
is to emphasize the need for change.  Sources of 
complacency must be identified and eliminated for 
the change to begin. 
“With complacency high, 
transformations usually go nowhere 
because few people are even 
interested in working on the change 
problem.  With urgency low, it’s 
difficult to put together a group with 
enough power and credibility to 
guide the effort or to convince key 
individuals to spend the time 
necessary to create and communicate 
a change vision” (Kotter, 1996).   
Kotter explains that sources of complacency include 
the absence of a major visible crisis, low performance 
standards by individuals, human nature, and capacity 
for denial.   
Applying these ideas to the influenza vaccine 
issue, the sources of complacency are the mistrust of 
vaccine safety, belief that vaccines are ineffective and 
thus will not help the issue, and the belief that the 
individual cannot make a difference in increasing the 
number of vaccine inoculations. 
To remove and/or minimize the sources of 
complacency, the public needs to be made aware of 
the positive and negative sides of receiving a vaccine.  
Campaigns need to respect the intelligence of the 
individual while emphasizing the importance of 
vaccination for society as a whole, the family unit, 
and the individual.   
Step 2: Create the Guiding Coalition 
The second step in the Kotter’s leadership 
action plan is to select a group to lead the campaign 
for change. This group must be able to adapt to the 
ever-changing market, must be large enough to have 
political power, must be experts in the field while 
still representing various points of view, and must 
have enough credibility to be taken seriously 
(Kotter, 1996). 
State health departments may be the best option 
to lead the influenza vaccine campaign. The CDC 
would have the most political clout, but state health 
organizations have the ability to design their 
programs for the needs of their own state. State 
health departments can create educational programs 
within schools, as well as within insurance 
companies and other health-related groups. State 
departments may be able to reach the public using 
local media in ways that may be difficult for a federal 
organization like the CDC.   
Step 3: Develop a Vision and Strategy 
After designating a leadership group to guide 
the change, goals and visions for the future must be 
established. “Vision refers to a picture of the future 
with some implicit or explicit commentary on why 
people should strive to create that future” (Kotter, 
1996). Kotter explains that these goals should not be 
authoritarian in nature and that they should not 
micromanage the groups and individuals within the 
overall corporation/population. Instead, the strategy 
should work to clarify the goals of the campaign and 
should motivate those affected by the change. 
Visions should be imaginable, desirable, feasible, 
focused, flexible, and easily communicable (Kotter, 
1996).   
The visions for an influenza vaccine campaign 
should be geared towards those at greatest risk for 
complications from the flu and then should expand 
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to include the general population. Those at greater 
risk for complications are young children, adults 65 
and older, pregnant women as well as people with 
certain chronic illnesses such as asthma, heart 
disease and weakened immune systems (CDC, 
2011a). The goals should include not only increasing 
the number of vaccinations, but also educating the 
population and encouraging trust in the state health 
departments, the CDC, and vaccine companies.   
Steps 4 and 5: Communicating the Change Vision and 
Empowering Broad-based Action 
The next steps in the leadership process are 
advertising and carrying out the campaign’s visions.  
Kotter (1996) is clear that when trying to achieve 
the group’s vision, the leadership coalition should 
not limit the capabilities of the population and 
should not underestimate the power of the 
individual. The campaign should communicate its 
goals in a simple but effective way using multiple 
techniques. The leaders should teach by example. 
Also, like any good persuasive argument, the 
campaign should acknowledge counter arguments 
and should respectfully refute their statements. 
Part of empowering broad-based action is to 
identify other sources of complacency and barriers 
that may have not been evident while organizing the 
leadership change (Kotter, 1996). By providing 
training to individuals outside of the guiding 
coalition while still maintaining the essential 
structure of the campaign, individuals within the 
target population can take actions on their own to 
help achieve the organization’s goals. 
Communicating the vision for increasing the 
number of influenza vaccinations should be 
respectful of individual autonomy and should 
effectively communicate both the benefits and risks 
of receiving a flu shot. Flu shot campaigns should 
include all types of media and there should be 
opportunities for the public to discuss their concerns 
and provide feedback. Effective communication 
between the guiding coalition and the target 
population will lead to an increase in autonomy, 
allowing individuals to make their own informed and 
educated decisions. Individuals within the target 
population will become the informants, possibly 
leading to a snowball effect of encouraging others to 
get vaccines.   
Steps 6 and 7: Generate Short-term Wins and 
Consolidate Gains to Produce More Change 
Short-term wins are necessary to evaluate the 
effectiveness of the leadership change. According to 
Kotter (1996), a good short term win is visible, 
unambiguous and clearly related to the change 
effort, meaning that the result is clear, easily 
distinguished and is a natural step towards achieving 
the overall vision. It is also important that the 
guiding coalition does not lose motivation after the 
first few goals are achieved. “Whenever you let up 
before the job is done, critical momentum can be lost 
and regression may follow” (Kotter, 1996). Short-
term gains should be recognized and the group 
needs to be immediately motivated to work towards 
the next goal.  
Part of reducing momentum-loss is to recognize 
interdependencies within the guiding coalition and 
to eliminate those that are unnecessary (Kotter, 
1996). Codependency can hold groups back by 
attempting to serve more than one agenda. By 
eliminating extraneous and outside factors, 
campaigns can continue to grow to their full 
potential.  
Short-term goals in vaccine campaigns can be 
measured by the increase in numbers of vaccinated 
individuals and by cross-sectional studies on beliefs 
about vaccine importance, effectiveness and safety, 
as well as the trust in government vaccine 
campaigns.  Once goals are achieved, their results 
should be distributed to the public, encouraging 
more people to take action. 
By breaking up interdependencies within 
influenza vaccine campaigns, individual groups may 
be able to gain more ground and reach separate 
populations. For example, health insurance 
companies working with multiple doctors’ offices to 
campaign for increasing vaccine inoculations could 
work with each doctors’ office separately to begin 
campaigning on their own. Each doctors’ office 
would be better able to target their campaign 
towards the individuals they are serving rather than 
the larger population of multiple offices.   
Step 8: Anchor New Approaches in Culture 
The final step in Kotter’s approach to leadership 
change is to ingrain the goals of the organization 
into the goals of the culture. “Until changed 
practices attain a new equilibrium and have been 
driven into the culture, they can be very fragile” 
(Kotter, 1996).  Inconsistencies between the modern 
culture and the goals of the campaign should be 
confronted and addressed; otherwise the changes 
made by the organization will be defaulted back to 
attitudes present before the campaign began. 
There is an inconsistency between goals of 
vaccine campaigns and the values of society. This 
inconsistency mainly revolves around the 
trust/mistrust of government safety tests for 
influenza vaccines and the necessity of getting a 
vaccine in the first place. To gain the public’s trust, 
the vaccine campaigns need to be educational. The 
guiding coalitions need to trust the public to make 
informed decisions regarding their autonomy based 
on the education the coalition provides to them. 
Vaccine campaigns need to explain the effectiveness 
of safety tests and vaccine statistics to gain the 
public’s trust. If the goals of the campaign are going 
to be ingrained in society, society has to trust that 
the goals are both reasonable and honest.   
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To increase the amount of influenza 
vaccinations amongst populations in the U.S., the 
CDC and state health departments should 
incorporate John Kotter’s eight-step process of 
leadership change. By developing short-term and 
long-term goals, health departments can continue to 
gain momentum in educating the public about the 
effectiveness and necessity of influenza inoculation. 
Eventually the goals of the health department will 
be incorporated into the mainstream goals of society, 
leading to a permanent health change.   
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